tisotumab vedotin shows clinically meaningful os improvement versus chemo for metastatic cervica...
Published 8 months ago • 31 plays • Length 2:47Download video MP4
Download video MP3
Similar videos
-
4:44
safety and efficacy profile of tisotumab vedotin for recurrent or metastatic cervical cancer
-
4:58
tisotumab vedotin for metastatic cervical cancer: results from esmo 2023 with brian slomovitz, md
-
2:10
highlights on tisotumab vedotin 2l or 3l recurrent or metastatic cervical cancer: innovatv 301
-
0:47
”as a cervical cancer patient, what results can i expect from the drug tisotumab vedotin?"
-
1:24
evaluating next steps for tisotumab vedotin in recurrent or metastatic cervical cancer
-
1:03
dr sun on tisotumab vedotin in recurrent or metastatic hnscc
-
0:55
dr. monk on the mechanism of action of tisotumab vedotin in recurrent cervical cancer
-
0:57
dr. monk on the utility of tisotumab vedotin in recurrent cervical cancer
-
0:57
dr. hong on the mechanism of action of tisotumab vedotin in cervical cancer
-
1:45
dr. hong on the safety profile of tisatumab vedotin in cervical cancer
-
0:54
dr. hong on moving tisotumab vedotin to frontline therapy for cervical cancer
-
0:38
tumor simultations offer insight into treatment options
-
44:32
interventional immunotherapy: transforming the treatment of solid tumors
-
2:03
dr. strosberg on the results of the netter-1 trial
-
1:36
dr. seiwert on prognosis for patients with head and neck cancer
-
1:18
section 3: tumor microenvironment
-
1:03
tufts medical center, carestream vue pacs, and lesion management
-
1:30
nativis clinical trial
-
4:37
therapeutic options for tls: a review of phase iii data